1. Home
  2. ICCC vs CSPI Comparison

ICCC vs CSPI Comparison

Compare ICCC & CSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$10.41

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Logo CSP Inc.

CSPI

CSP Inc.

HOLD

Current Price

$8.25

Market Cap

85.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
CSPI
Founded
1982
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
93.1M
85.6M
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
ICCC
CSPI
Price
$10.41
$8.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.4K
73.5K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
1.15%
EPS Growth
53.85
75.00
EPS
0.21
0.04
Revenue
$26,493,169.00
$58,730,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$47.90
$205.75
Revenue Growth
51.64
6.36
52 Week Low
$4.52
$7.51
52 Week High
$11.16
$15.00

Technical Indicators

Market Signals
Indicator
ICCC
CSPI
Relative Strength Index (RSI) 57.62 41.95
Support Level $9.27 $7.98
Resistance Level $10.75 $9.09
Average True Range (ATR) 0.47 0.58
MACD 0.02 -0.03
Stochastic Oscillator 55.24 33.33

Price Performance

Historical Comparison
ICCC
CSPI

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About CSPI CSP Inc.

CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.

Share on Social Networks: